Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
CIHR Canadian HIV Trials Network
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00143702
First received: August 31, 2005
Last updated: September 24, 2008
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)